Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy
2018
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Current State of knowledge on Takotsubo Syndrome: A Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology
2015 Standout
Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics
2013 StandoutNobel
Universal Definition of Myocardial Infarction: Clinical Insights
2015 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Evidence-Based Management of Anticoagulant Therapy
2012
Perioperative Management of Antithrombotic Therapy
2012 Standout
Oral Anticoagulant Therapy
2012 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists?
2009
Antithrombotic Therapy for VTE Disease
2012 Standout
Warfarin Interactions With Substances Listed in Drug Information Compendia and in the FDA-Approved Label for Warfarin Sodium
2009
Executive Summary
2012 Standout
Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents
2011
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Atherosclerosis
2019 Standout
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Influence of dietary vitamin K intake on subtherapeutic oral anticoagulant therapy
2010
Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysis
2017
French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding)
2010
Corporate transformation toward Industry 4.0 and financial performance: The influence of environmental, social, and governance (ESG)
2021 Standout
Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis
2019
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Fourth universal definition of myocardial infarction (2018)
2018 Standout
Effects of technological changes on China's carbon emissions
2020
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Hematological findings and complications of COVID ‐19
2020 Standout
Works of Luqi Wang being referenced
Quality of anticoagulation and use of warfarin-interacting medications in long-term care: A chart review
2008
Comparative evaluation of global low-carbon urban transport
2019
Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin
2009